Design and Evaluation of a Multiplexed Assay to Assess Human Immunogenicity Against Humira

Watch a 46-minute webinar exploring the development and validation of a multiplexed assay for assessing immunogenicity against biologic therapeutics, presented by Dr. Paul Rhyne, a bioassay leader at Gates Medical Research Institute. Learn how biologic-based therapeutics can generate anti-drug immune responses in clinical patients, potentially affecting drug efficacy and patient safety. Discover the traditional tiered approach to anti-drug antibody testing and understand how multiplexing screening and isotyping assays using Luminex® xMAP® Technology can streamline characterization while reducing sample handling. Gain insights into FDA-recommended guidelines for immunogenicity assessments and see how multiplexed assays compare to industry standards. PACE credits are available for registered Labroots members who complete the webinar viewing requirements before October 16, 2026.